Arylcycloalkyl derivatives with branched side chains as PPAR receptor modulators, method for their production and their use as medicaments

Details for Australian Patent Application No. 2004215675 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Goerlitzer, Jochen; Glombik, Heiner; Falk, Eugen; Schaefer, Hans-Ludwig; Gretzke, Dirk; Stapper, Christian; Wendler, Wolfgang; Keil, Stefanie

Agent Watermark

Pub. Number AU-B-2004215675

PCT Pub. Number WO2004/076402

Priority 103 08 352.9 27.02.03 DE

Filing date 19 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 21 January 2010

International Classifications

C07D 213/40 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

C07D 211/06 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 279/12 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 295/13 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076402 Priority application(s): WO2004/076402

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

21 January 2010 Application Accepted

  Published as AU-B-2004215675

20 May 2010 Standard Patent Sealed

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215676-Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament

2004215674-Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives